Responses
Other content recommended for you
- Rescuing the duty to rescue
- Live attenuated influenza vaccine for children
- Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
- Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain–Barré syndrome
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- Socioeconomic, cultural and behavioural features of prior and anticipated influenza vaccine uptake in urban and rural Pune district, India: a mixed-methods case study
- Should all children be immunised against influenza?
- Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study
- Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case–control study
- Considerations for vaccinating children against COVID-19